Particle.news
Download on the App Store
8 ARTICLES
·
last mo.

Shingles Vaccine Linked to 20% Reduction in Dementia Risk, Study Finds

New research published in Nature strengthens evidence of a causal relationship and calls for further trials to confirm findings and explore mechanisms.

Professor Ruth Itzhaki has to stop herself from feeling bitter about the way she was treated
Image
Image
Image

Overview

  • A study published in Nature on April 2, 2025, shows a 20% lower risk of dementia among individuals vaccinated against shingles, based on a natural experiment in Wales.
  • The study utilized an age-based eligibility cutoff from Wales' 2013 shingles vaccination program, providing robust comparative data to minimize biases.
  • Researchers propose that the vaccine may reduce dementia risk by preventing viral reactivation, reducing inflammation, or through broader immune system effects.
  • Women experienced stronger protective effects from the vaccine, potentially due to differences in immune responses, highlighting gender-specific benefits.
  • Calls for randomized controlled trials are growing to confirm the findings, explore underlying mechanisms, and assess the potential of newer vaccines like Shingrix.